MG217 Psoriasis

MG217 Psoriasis is an FDA drug label for the active ingredient SALICYLIC ACID manufactured by Wisconsin Pharmacal Company administered by TOPICAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20160303.

Generic: SALICYLIC ACID

Manufacturer: Wisconsin Pharmacal Company

Product Type: HUMAN OTC DRUG

Route: TOPICAL

Dosage Form:

NDC: 68093-7203

Application: part333D

Effective: 20160303

Active Ingredients: Active Ingredient Salicylic Acid 3%

Indications & Usage

Uses For the relief of itching, scaling, redness, flaking and irritation associated with psoriasis and/or seborrheic dermatitis. Helps prevents symptom recurrence.

Dosage & Administration

Directions Apply to affected area 1 to 4 times daily, or as directed by a doctor.

Contraindications

Not available.

Warnings

Warnings For external use only. Avoid contact with the eyes If contact occurs, rinse eyes thoroughly with water.

Adverse Reactions

Not available.

More from same ingredient

ACNE AND LINE CORRECTING SERUM

CLINIQUE LABORATORIES LLC

ACNE CLEANSING

CLINIQUE LABORATORIES LLC

Acne Advanced Clarifying Hydrator

Eminence Organic Skin Care Ltd.

Acne Advanced Clarifying Masque

Eminence Organic Skin Care Ltd.

Acne Advanced Cleansing

Eminence Organic Skin Care Ltd.